Year: 2009
Type: article
Abstract: Staphylococcus aureus is one of the most common causative pathogens of bloodstream infections (BSIs). In approximately one-half of patients with S. aureus BSI, no portal of entry can be documented. This group of patients has a high risk of developing septic metastases. Similarly, patient populations at high risk of S. aureus BSI and BSI-associated complications include patients receiving hemodialysis, injection drug users, patients with diabetes, and patients with preexisting cardiac conditions or other comorbidities. One of the most severe complications of S. aureus BSI is infective endocarditis, and S. aureus is now the most common cause of infective endocarditis in the developed world. Patients with methicillin-resistant S. aureus BSI or infective endocarditis have higher rates of mortality, compared with patients with methicillin-susceptible S. aureus infection. Nasal carriage is the most important source of S. aureus BSI. Better eradication and control strategies, including nasal decolonization and more-active antibiotics, are needed to combat S. aureus BSIs.
Source: Clinical Infectious Diseases
DOI: 10.1086/598187
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Keywords: Staphylococcus aureus, bloodstream infection, infective endocarditis, methicillin-resistant Staphylococcus aureus, methicillin-susceptible Staphylococcus aureus, hemodialysis, people who inject drugs, diabetes mellitus, cardiovascular comorbidity, nasal carriage, nasal decolonization, mortality, risk factors
Open Access status: bronze
Awards: G1123387284, G837631903
OpenAlex ID: W2143000308
